DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

XenoPort, Inc. (NASDAQ: XNPT)



company name or ticker

Xenoport: One Door Closed, Two More Opened

XenoPort Is Now Oversold (XNPT)

XenoPort's Loss Widens Y/Y - Analyst Blog

XenoPort's CEO Discusses Q2 2013 Results - Earnings Call Transcript

XenoPort Announces Inclusion of Horizant (Gabapentin Enacarbil) in Guidelines for Long-Term Treatmen

XenoPort Announces Inclusion of Horizant (Gabapentin Enacarbil) in Guidelines for Long-Term Treatment of Restless Legs Syndrome/Willis-Ekbom Disease

Alkermes Adds Multiple Sclerosis Pill To Expanding Pipeline

3 Biotech Stocks Under $10 Spiking Higher

August 17th Options Now Available For XenoPort (XNPT)

Does Restless Legs Syndrome Really Shorten Life Span?

A new study suggests a link between this neurological disorder and mortality rates in men.

Mid-Day Update: Benzinga's Top Downgrades